PA8680201A1 - Proceso de elaboración para tigeciclina - Google Patents

Proceso de elaboración para tigeciclina

Info

Publication number
PA8680201A1
PA8680201A1 PA20068680201A PA8680201A PA8680201A1 PA 8680201 A1 PA8680201 A1 PA 8680201A1 PA 20068680201 A PA20068680201 A PA 20068680201A PA 8680201 A PA8680201 A PA 8680201A PA 8680201 A1 PA8680201 A1 PA 8680201A1
Authority
PA
Panama
Prior art keywords
tigecicline
elaboration process
elaboration
adequate
preparation
Prior art date
Application number
PA20068680201A
Other languages
English (en)
Spanish (es)
Inventor
Richard William Saunders
Mahdi B Fawzi
Gurmukh Chanana
Dominic Ventura
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PA8680201A1 publication Critical patent/PA8680201A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
PA20068680201A 2005-06-16 2006-06-16 Proceso de elaboración para tigeciclina PA8680201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69117305P 2005-06-16 2005-06-16

Publications (1)

Publication Number Publication Date
PA8680201A1 true PA8680201A1 (es) 2007-01-17

Family

ID=37111782

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20068680201A PA8680201A1 (es) 2005-06-16 2006-06-16 Proceso de elaboración para tigeciclina

Country Status (22)

Country Link
US (1) US7705168B2 (cg-RX-API-DMAC7.html)
EP (1) EP1898884A2 (cg-RX-API-DMAC7.html)
JP (3) JP2008543871A (cg-RX-API-DMAC7.html)
KR (1) KR20080024201A (cg-RX-API-DMAC7.html)
CN (1) CN101198315A (cg-RX-API-DMAC7.html)
AR (1) AR055336A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006261636A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0612228A2 (cg-RX-API-DMAC7.html)
CA (1) CA2610909A1 (cg-RX-API-DMAC7.html)
CR (1) CR9594A (cg-RX-API-DMAC7.html)
EC (1) ECSP078005A (cg-RX-API-DMAC7.html)
GT (1) GT200600259A (cg-RX-API-DMAC7.html)
IL (1) IL187979A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007015960A (cg-RX-API-DMAC7.html)
NO (1) NO20076264L (cg-RX-API-DMAC7.html)
PA (1) PA8680201A1 (cg-RX-API-DMAC7.html)
PE (1) PE20070072A1 (cg-RX-API-DMAC7.html)
RU (1) RU2007145595A (cg-RX-API-DMAC7.html)
SV (1) SV2007002575A (cg-RX-API-DMAC7.html)
TW (1) TW200716203A (cg-RX-API-DMAC7.html)
WO (1) WO2006138641A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200710906B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2007713A2 (en) * 2006-04-17 2008-12-31 Teva Pharmaceutical Industries Ltd Isolation of tetracycline derivatives
DK2016045T3 (en) * 2006-04-24 2015-02-02 Teva Pharma TIGECYCLIN CRYSTAL FORM AND PROCEDURES FOR PREPARING IT
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
MX2008009520A (es) * 2006-11-29 2009-02-26 Teva Pharma Formas cristalinas de tigeciclina y procesos de preparacion de ellas.
US20080234504A1 (en) * 2006-11-30 2008-09-25 Evgeny Tsiperman Processes for preparation of 9-haloacetamidominocyclines
EP2114865A1 (en) * 2007-03-01 2009-11-11 Teva Pharmaceutical Industries Ltd. Processes for purification of tigecycline
WO2009052152A2 (en) * 2007-10-16 2009-04-23 Wyeth Tigecycline and methods of preparing intermediates
US9107929B2 (en) 2008-05-01 2015-08-18 Ranbaxy Laboratories Limited Stable parenteral formulations of tigecycline
ITMI20080807A1 (it) 2008-05-05 2009-11-06 Antibioticos Spa Procedimento per la preparazione di tigeciclina in forma amorfa
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
PT104350A (pt) 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
CA2751238A1 (en) 2009-03-12 2010-10-07 Wyeth Llc Nitration of tetracyclines
CN103417498B (zh) * 2012-05-18 2017-09-12 山东新时代药业有限公司 一种替加环素冻干粉针剂的制备方法
WO2014167575A2 (en) 2013-03-26 2014-10-16 Astron Research Limited Stable tigecycline composition
IN2013MU01127A (cg-RX-API-DMAC7.html) 2013-03-26 2015-05-01 Astron Res Ltd
CN103202814A (zh) * 2013-04-23 2013-07-17 成都百裕科技制药有限公司 一种注射用替加环素的制备方法
CN105924367B (zh) * 2016-04-18 2017-12-29 镇江高海生物药业有限公司 多西环素一水物的有关物质及其分析检测方法
WO2019147755A1 (en) * 2018-01-26 2019-08-01 AL Pharma, Inc. Manufacturing and packaging of a sterile drug product
CN108653216B (zh) * 2018-05-28 2020-12-18 福安药业集团湖北人民制药有限公司 注射用替加环素
WO2021063468A1 (en) 2019-10-02 2021-04-08 Anfarm Hellas S.A. Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof
CN116531322A (zh) * 2023-06-27 2023-08-04 遂成药业股份有限公司 一种高稳定性呋塞米注射液及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3026248A (en) * 1959-09-11 1962-03-20 Pfizer & Co C Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5284963A (en) 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US6660267B1 (en) * 1992-12-21 2003-12-09 Promega Corporation Prevention and treatment of sepsis
US5675030A (en) 1994-11-16 1997-10-07 American Cyanamid Company Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound
WO2003099217A2 (en) * 2002-05-23 2003-12-04 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
KR20070069182A (ko) * 2004-10-28 2007-07-02 와이어쓰 티게시클린 및 디곡신의 공동투여
WO2006099258A1 (en) * 2005-03-14 2006-09-21 Wyeth Tigecycline compositions and methods of preparation
AR057034A1 (es) 2005-05-27 2007-11-14 Wyeth Corp Metodos para purificar tigeciclina

Also Published As

Publication number Publication date
AR055336A1 (es) 2007-08-22
US20070026080A1 (en) 2007-02-01
RU2007145595A (ru) 2009-07-27
KR20080024201A (ko) 2008-03-17
PE20070072A1 (es) 2007-02-25
CN101198315A (zh) 2008-06-11
BRPI0612228A2 (pt) 2011-03-29
ZA200710906B (en) 2009-03-25
JP2008543871A (ja) 2008-12-04
WO2006138641A3 (en) 2007-05-18
MX2007015960A (es) 2008-03-06
ECSP078005A (es) 2008-01-23
JP2010024252A (ja) 2010-02-04
CR9594A (es) 2008-03-07
AU2006261636A1 (en) 2006-12-28
US7705168B2 (en) 2010-04-27
SV2007002575A (es) 2007-01-03
TW200716203A (en) 2007-05-01
EP1898884A2 (en) 2008-03-19
CA2610909A1 (en) 2006-12-28
WO2006138641A2 (en) 2006-12-28
IL187979A0 (en) 2008-03-20
GT200600259A (es) 2007-05-08
NO20076264L (no) 2008-03-10
JP2009191083A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
PA8680201A1 (es) Proceso de elaboración para tigeciclina
LTPA2020536I1 (lt) Nauji anti-CD38 antikūnai, skirti vėžio gydymui
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
CR10157A (es) Compuestos químicos
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
TW200731094A (en) Extensible meta-data
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
EA200802213A1 (ru) Способы лечения заболеваний крови
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
CY1111793T1 (el) Μυκητοκτονες συνθεσεις
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
AR069531A1 (es) Derivados de indolinona y procedimiento para su fabricacion
CY1117860T1 (el) Διαβλεννογονια χορηγηση 2-(10-υδροξυδεκυλ)-5,6-διμεθοξυ-3-μεθυλ-2,5-κυκλοεξαδιενο-1,4-διονης (ιδεβενονη)
AR063188A1 (es) Compuestos intermediarios para la preparacion de trans -5-cloro-2-netil-2,3,3a,12b- tetrahidro-1h-dibenz (2,3:6,7)- oxepina (4,5c) pirrol
NO20090738L (no) Tilveiebringelse av EP2 agonister, fremgangsmate for fremstilling derav, farmasoytiske sammensetninger inneholdende disse forbindelser og fremgangsmater for anvendelse av forbindelsene og sammensetningene for a senke intraokkulaert trykk og behandle glaukom
UY31688A1 (es) Plaguicidas
CY1106579T1 (el) Μεθοδος για την παρασκευη συμπλοκων 1,2-διαμινοκυκλοεξανιου-δισθενους πλατινης
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
DOP2009000088A (es) Pirazoles sustituidos que presentan actividad anticancerígena
EA200900261A1 (ru) Применение эсцина